Literature DB >> 23259472

NHLBI integrated pediatric guidelines: battle for a future free of cardiovascular disease.

Justin P Zachariah1, Sarah D de Ferranti.   

Abstract

The report of the National Heart, Lung and Blood Institute Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents collects into one document atherosclerotic disease prevention in pediatric age groups. The guidelines summarize the evidence base and make recommendations that encourage universal adoption of healthier lifestyles, identification of children with cardiovascular disease risk factors, and treatment of those risk factors using targeted lifestyle modification and rarely pharmacotherapy. These recommendations highlight childhood as a frontier for cardiovascular disease prevention. The guideline recommendations are controversial and not universally embraced, but at the very least, they suggest directions for important research. This article explores key facets of the guidelines, controversies and future directions in preventive cardiology for children.

Entities:  

Mesh:

Year:  2013        PMID: 23259472      PMCID: PMC3705707          DOI: 10.2217/fca.12.72

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  69 in total

1.  Statin use in children in the United States.

Authors:  Tamar Lasky
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

Review 2.  Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects.

Authors:  Clodagh S O'Gorman; Mary F Higgins; Michael B O'Neill
Journal:  Pediatr Cardiol       Date:  2009-02-03       Impact factor: 1.655

3.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

4.  Greater dietary intake of simple carbohydrate is associated with lower concentrations of high-density-lipoprotein cholesterol in hypercholesterolemic children.

Authors:  T J Starc; S Shea; L C Cohn; L Mosca; W M Gersony; R J Deckelbaum
Journal:  Am J Clin Nutr       Date:  1998-06       Impact factor: 7.045

5.  Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors: 
Journal:  Arterioscler Thromb       Date:  1993-09

6.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

7.  Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.

Authors:  Joshua N Liberman; Jan E Berger; Meredith Lewis
Journal:  Arch Pediatr Adolesc Med       Date:  2009-04

8.  Perceived risk and representations of cardiovascular disease and preventive behaviour in people diagnosed with familial hypercholesterolemia: a cross-sectional questionnaire study.

Authors:  Liesbeth Claassen; Lidewij Henneman; Iris Kindt; Theresa M Marteau; Danielle R M Timmermans
Journal:  J Health Psychol       Date:  2010-01

9.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

10.  Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases.

Authors:  A J Dobson; A Evans; M Ferrario; K A Kuulasmaa; V A Moltchanov; S Sans; H Tunstall-Pedoe; J O Tuomilehto; H Wedel; J Yarnell
Journal:  Ann Med       Date:  1998-04       Impact factor: 4.709

View more
  3 in total

Review 1.  Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review.

Authors:  Silva Hovsepian; Roya Kelishadi; Shirin Djalalinia; Farshad Farzadfar; Shohreh Naderimagham; Mostafa Qorbani
Journal:  J Res Med Sci       Date:  2015-05       Impact factor: 1.852

2.  A Pilot Randomized Controlled Clinical Trial to Assess Tolerance and Efficacy of Navy Bean and Rice Bran Supplementation for Lowering Cholesterol in Children.

Authors:  Erica C Borresen; NaNet Jenkins-Puccetti; Katie Schmitz; Dustin G Brown; Austin Pollack; Amanda Fairbanks; Melissa Wdowik; Sangeeta Rao; Tracy L Nelson; Gary Luckasen; Elizabeth P Ryan
Journal:  Glob Pediatr Health       Date:  2017-02-16

3.  Prediction of dyslipidemia using gene mutations, family history of diseases and anthropometric indicators in children and adolescents: The CASPIAN-III study.

Authors:  Hamid R Marateb; Mohammad Reza Mohebian; Shaghayegh Haghjooy Javanmard; Amir Ali Tavallaei; Mohammad Hasan Tajadini; Motahar Heidari-Beni; Miguel Angel Mañanas; Mohammad Esmaeil Motlagh; Ramin Heshmat; Marjan Mansourian; Roya Kelishadi
Journal:  Comput Struct Biotechnol J       Date:  2018-03-02       Impact factor: 7.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.